Your browser doesn't support javascript.
loading
First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023.
Rasmussen, Morten; Møller, Frederik Trier; Gunalan, Vithiagaran; Baig, Sharmin; Bennedbæk, Marc; Christiansen, Lasse Engbo; Cohen, Arieh Sierra; Ellegaard, Kirsten; Fomsgaard, Anders; Franck, Kristina Træholt; Larsen, Nicolai Balle; Larsen, Tine Graakjær; Lassaunière, Ria; Polacek, Charlotta; Qvesel, Amanda Gammelby; Sieber, Raphael Niklaus; Rasmussen, Lasse Dam; Stegger, Marc; Spiess, Katja; Tang, Man-Hung Eric; Vestergaard, Lasse Skafte; Andersen, Thomas Emil; Hoegh, Silje Vermedal; Pedersen, Rune Micha; Skov, Marianne Nielsine; Steinke, Kat; Sydenham, Thomas Vognbjerg; Hoppe, Morten; Nielsen, Lene; Krause, Tyra Grove; Ullum, Henrik; Jokelainen, Pikka.
Afiliación
  • Rasmussen M; Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Møller FT; These authors contributed equally to this work and share first authorship.
  • Gunalan V; These authors contributed equally to this work and share first authorship.
  • Baig S; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Bennedbæk M; Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Christiansen LE; Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Cohen AS; Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Ellegaard K; Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Fomsgaard A; TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Franck KT; Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Larsen NB; Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Larsen TG; Virus Surveillance and Research Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Lassaunière R; TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Polacek C; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Qvesel AG; Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Sieber RN; Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Rasmussen LD; Virus Surveillance and Research Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Stegger M; Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Spiess K; Virus Surveillance and Research Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Tang ME; Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Vestergaard LS; Antimicrobial Resistance and Infectious Diseases Laboratory, Harry Butler Institute, Murdoch University, Perth, Australia.
  • Andersen TE; Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Hoegh SV; Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Pedersen RM; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Skov MN; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
  • Steinke K; Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark.
  • Sydenham TV; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
  • Hoppe M; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
  • Nielsen L; Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark.
  • Krause TG; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
  • Ullum H; Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark.
  • Jokelainen P; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Euro Surveill ; 28(36)2023 09.
Article en En | MEDLINE | ID: mdl-37676147
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca